Company / Interest Expense per Share
ADMA Biologics, Inc. Interest Expense per Share History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.11
FY2023
5-year range
$0.07 / $0.12
FY2019-FY2023
Trend
+69.2%
vs FY2022
Sector context
#23 of 43
Health Care
What the data says
At $0.11, ADMA Biologics, Inc.'s interest expense per share ranks #21 of 43 in the Health Care sector. Interest Expense per Share returned to growth in FY2023 after 2 years of decline, reaching $0.11.
Based on SEC 10-K filings.
0.11 in FY2023 with a 5-year CAGR of -5.6%.
Improved from $0.12 to $0.11 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -17.7%
- 5-Year CAGR
- -5.6%
- 10-Year CAGR
- -
Sector benchmark
#21 of 43 in Health CareTop 47% of 43This company $0.11 Sector average $9.80
▼
-98.8% below sector average
Key checks
Key Insights
- In FY2023, interest expense per share increased 69.2% year-over-year.
- Ranks #23 out of 43 companies in the Health Care sector.
- Peak interest expense per share was recorded in FY2016.
- Lowest interest expense per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 3.37 (safe zone, above 2.9 threshold)
- Strong profit margin: 46.4%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $0.11 | +69.2% |
| FY2022 | $0.07 | -46.4% |
| FY2021 | $0.12 | -38.4% |
| FY2020 | $0.20 | +4.1% |
| FY2019 | $0.19 | +29.0% |
| FY2018 | $0.15 | -13.5% |
| FY2017 | $0.17 | -16.9% |
| FY2016 | $0.21 | +51.0% |
As of FY2023 · SEC 10-K · Updated Jul 1, 2026